1 |
Bai X, Liu X, Li S, An H, Kang X, Guo S. Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer. J Agric Food Chem 2022. [PMID: 35298888 DOI: 10.1021/acs.jafc.1c08375] [Reference Citation Analysis]
|
2 |
Rugamba A, Kang DY, Sp N, Jo ES, Lee JM, Bae SW, Jang KJ. Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells. Cells 2021;10:1632. [PMID: 34209829 DOI: 10.3390/cells10071632] [Reference Citation Analysis]
|
3 |
Romanucci V, Pagano R, Lembo A, Capasso D, Di Gaetano S, Zarrelli A, Di Fabio G. Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines. Molecules 2022;27:1702. [DOI: 10.3390/molecules27051702] [Reference Citation Analysis]
|
4 |
Guo S, Bai X, Shi S, Deng Y, Kang X, An H. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. Int J Mol Sci 2021;22:10930. [PMID: 34681590 DOI: 10.3390/ijms222010930] [Reference Citation Analysis]
|
5 |
Addeo R. Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer. J Exp Pharmacol 2021;13:901-3. [PMID: 34611448 DOI: 10.2147/JEP.S326871] [Reference Citation Analysis]
|